Best Xavier Small Podcasts (2025)

1
Relinquishing the Patriarchy: Talking adrienne maree brown with Sandhya Sudhakar 54:24

5h ago54:24

54:24

Becky Mollenkamp and Sandhya Sudhakar dive into adrienne maree brown’s blog post "Relinquishing the Patriarchy." This rich, layered discussion covers gender roles, emotional labor, discomfort, and how patriarchy harms us all. From parenting to dating, personal identity to privilege, they explore how internalized systems shape us—and what it really …

1
S13 Ep33: Isatuximab-Based Triplet Delivered via On-Body System Shows Promise in RRMM: With Xavier Leleu, MD, PhD; and Beth Faiman, PhD, MSN, APN-BC 21:40

5h ago21:40

21:40

In our exclusive interview, Drs Leleu and Faiman discussed the unique methods and design of IRAKLIA, key efficacy and safety findings from this trial, and the benefits of using on-body delivery systems to deliver effective therapies to patients in more convenient and patient-centered ways.By OncLive® On Air

1
DYKWYB: Angelology 1 20:16

2d ago20:16

20:16

Introduction to Angels

1
S13 Ep32: European Approval of Zanidatamab Expands Treatment Options for HER2+ Biliary Tract Cancer: With Arndt Vogel, MD 11:54

4d ago11:54

11:54

In today’s episode, we had the opportunity to speak with Arndt Vogel, MD, about the European Commission’s (EC's) July 2025 marketing authorization of zanidatamab-hrii (Ziihera) for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic HER2-positive biliary tract cancer. Dr Vogel is a faculty member at…

1
S13 Ep31: IHC Testing Leads to Early Detection of TP43-Mutant AML and MDS: With Jonathan M. Gerber, MD; and Shyam A. Patel, MD, PhD 28:45

5d ago28:45

28:45

In today’s episode, we had the pleasure of speaking with Jonathan M. Gerber, MD; and Shyam A. Patel, MD, PhD, about a study they conducted investigating the use of immunohistochemistry (IHC) as a biomarker for early TP53 mutation identification in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Dr Gerber is a member …

1
S13 Ep30: Biopsy-Guided Approach Enables Surgery Omission After pCR in HER2+ and Triple-Negative Breast Cancer: With Henry M. Kuerer, MD, PhD, FACS, CMQ 18:29

6d ago18:29

18:29

In today’s episode, we had the opportunity to speak with Henry M. Kuerer, MD, PhD, FACS, CMQ, about the potential to safely omit surgery in a subset of patients with early-stage HER2-positive or triple-negative breast cancer who achieve a pathologic complete response (pCR) following neoadjuvant systemic therapy. Dr Kuerer is a professor of breast s…

1
Feminist Porn Critique: Unpacking Andrea Dworkin’s Legacy with Goddess Erica 1:00:51

7d ago1:00:51

1:00:51

This week, Becky and Goddess Erica discuss Andrea Dworkin’s 1988 essay on pornography and power. They explore ethical porn, sex education reform, and the intersection of pleasure, patriarchy, and AI. A bold, vulnerable conversation about dismantling shame and building new systems for healing and desire. This week’s text: ✍️ “Pornography: Men Posses…

1
S13 Ep29: FDA Approval Insights: Oncomine DX Express Test Companion Diagnostic for Sunvozertinib in Non–Small Cell Lung Cancer: With Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP 11:14

8d ago11:14

11:14

In today’s episode, supported by Thermo Fisher Scientific, we had the pleasure of speaking with Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP, about the FDA approval of the Oncomine DX Express Test for use as a companion diagnostic for sunvozertinib (Zegfrovy) in EGFR exon 20 insertion mutation–positive non–small cell lung cancer…

1
DYKWYB: Ecclesiology 6 31:32

9d ago31:32

31:32

We wrap up our series on ecclesiology with the second half of the acronym B.A.P.T.I.S.T

1
S13 Ep28: Toripalimab Plus De-Intensified Chemo Represents the Potential Future of Nasopharyngeal Cancer Management: With Justine Bruce, MD 11:20

11d ago11:20

11:20

In today’s episode, supported by Coherus BioSciences, we had the pleasure of speaking with Justine Bruce, MD, about the ongoing evolution of nasopharyngeal carcinoma management. Dr Bruce is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine at the University of Wisconsin, as well a…

1
S13 Ep27: How Enthusiasm for Science and Global Change Culminates in Wide-Reaching Opportunities to Improve Cancer Care: D. Ross Camidge, MD, PhD; and Catharine Young, PhD 1:09:16

12d ago1:09:16

1:09:16

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Catharine Young, PhD, who is currently a sen…

1
What It Means to Do the Work: Feminism Beyond the Hashtags (with Kim Romain) 53:05

14d ago53:05

53:05

In this episode of Assigned Reading, Becky and Kim unpack Barbara Love’s essay on developing a liberatory consciousness. Using the framework of the “4 A’s”—Awareness, Analysis, Action, and Accountability—they reflect on the deeply personal work of moving from complicity to liberation. This episode explores queer identity, internalized oppression, w…

1
S13 Ep26: ASCO 2025 Plenary — MATTERHORN 12:14

14d ago12:14

12:14

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University…

1
DYKWYB: Ecclesiology 5 30:25

15d ago30:25

30:25

Baptist Polity Pt. 1

1
S13 Ep25: FDA Approval Insights: Darolutamide for Metastatic Castration-Sensitive Prostate Cancer: With Alicia Morgans, MD, MPH; and Neal Shore, MD, FACS 16:41

18d ago16:41

16:41

In today’s episode, supported by Bayer, we had the pleasure of speaking with Alicia Morgans, MD, MPH, and Neal Shore, MD, FACS, about the FDA approval of darolutamide (Nubeqa) plus androgen deprivation therapy for patients with metastatic castration-sensitive prostate cancer (mCSPC). Morgans is the medical director of the survivorship program at Da…

1
S13 Ep24: Biomarker-Directed Therapies Improve Outlooks for the mCRC Treatment Arsenal: With Chandler Park, MD; and Midhun Malla, MD 6:39

19d ago6:39

6:39

In this episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Midhun Malla, MD, of the University of Alabama at Birmingham, to discuss therapeutic options for patients with metastatic colorectal cancer (mCRC), particularly in the third-line sett…

1
The Truth About Aging and Gender Roles (with Ana Xavier) 58:08

21d ago58:08

58:08

Aging, feminism, and power collide in this juicy conversation. Becky and podcast producer Ana Xavier discuss Susan Sontag’s The Double Standard of Aging and how it still resonates decades later. From gray hair and menopause to child-free choices and decentering men, this feminist talk gets real about the aging double standard and what it means to o…

1
S13 Ep23: IMA203 emerges as a Novel Investigational Agent in Cutaneous Melanoma: With Justin Moser, MD 7:32

21d ago7:32

7:32

In today’s episode, supported by Immatics, we had the pleasure of speaking with Justin Moser, MD, about the ongoing phase 3 SUPRAME trial investigating the PRAME-directed T-cell receptor T-cell therapy IMA203 vs treatment of physician's choice in patients with previously treated, unresectable or metastatic cutaneous melanoma. Dr Moser is an associa…

1
DYKWYB: Ecclesiology 4 28:30

23d ago28:30

28:30

How are Christians supposed to respond to the government?

1
S13 Ep22: BRAF-Mutant and HER2+ mCRC Management Strategies Are Becoming Increasingly Tailored: With Chandler Park, MD, and Midhun Malla, MD 9:27

25d ago9:27

9:27

In this episode of MedNews Week's Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Midhun Malla, MD, a gastrointestinal oncologist at Allegheny Health Network in Pittsburgh, Pennsylvania, to discuss treatment personalization in metastatic colorectal cancer (mCRC), w…

1
S13 Ep21: T-DXd's Efficacy Stands Strong and Supports IHC Testing in HER2-Mutated NSCLC: With Misako Nagasaka, MD, PhD 6:18

26d ago6:18

6:18

In today’s episode, supported by Daiichi Sankyo, we had the pleasure of speaking with Misako Nagasaka, MD, PhD, about the use of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) in pretreated patients with HER2-mutated non–small cell lung cancer (NSCLC). Dr Nagasaka is an associate professor in the Division of Hematology and Oncology and the Divisi…

1
Episode #66: Alternative Recovery Solutions 27:02

27d ago27:02

27:02

On Episode 66 of the Musashi Podcast, the guys discuss some lesser-known techniques used to improve physical post-exercise resurgence – Alternative Recovery Solutions. The team speak about the supposed benefits of cupping, acupuncture, dry needling, and other recent emergences in the recovery space.

1
S13 Ep20: ASCO 2025 Plenary: SERENA-6 12:33

28d ago12:33

12:33

In this episode, OncLive On Air® partnered with Two Onc Docs to bring discussion of data from the phase 3 SERENA-6 trial (NCT04964934), which were presented at the 2025 ASCO Annual Meeting. SERENA-6 evaluated switching to camizestrant plus a CDK4/6 inhibitor vs continuing with a standard-of-care aromatase inhibitor plus a CDK4/6 inhibitor in the fr…

1
Understanding Kimberle Crenshaw’s Landmark Essay on Intersectionality (with Tori Williams Douglass) 55:19

28d ago55:19

55:19

What happens when the law can't see you? This episode dives into Kimberle Crenshaw’s landmark 1989 essay on intersectionality, exploring how courts systematically erase Black women. Becky and Tori break down Crenshaw’s trapdoor metaphor, legal analysis, and the continuing relevance of intersectional feminism today. This week’s text ✍️ “Demarginaliz…

1
S13 Ep19: Long-Term Data Underscore the Enduring Efficacy of PD-1 Inhibition in Nasopharyngeal Carcinoma: With Michael Dennis, MD 15:55

29d ago15:55

15:55

In today’s episode, supported by Coherus BioSciences, we had the pleasure of speaking with Michael Dennis, MD, about recent updates to the nasopharyngeal carcinoma treatment paradigm. Dr Dennis is a physician at Dana-Farber Cancer Institute; as well as an instructor in medicine at Harvard Medical School, both in Boston, Massachusetts. In our exclus…

1
DYKWYB: Ecclesiology 3 27:29

1M ago27:29

27:29

What was God’s Design for the Church?

1
S13 Ep18: Conversations About BTK Inhibitors and CAR T-Cell Therapies Bridge Gaps in Leukemia and Lymphoma: With Alexey Danilov, MD, PhD 19:58

1M ago19:58

19:58

In today’s episode, we had the pleasure of speaking with Alexey Danilov, MD, PhD, about current challenges and emerging treatment approaches for the management of leukemia and lymphoma that were published in a manuscript based on proceedings from the inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Dr Danilov is t…

1
S13 Ep17: 42nd Annual Miami Breast Cancer Conference® Podcast: OncLive On Air CE, Powered by PER 26:40

1M ago26:40

26:40

Episode Description In this podcast, expert Hope Rugo, MD, discusses her approach to treating patients with hormone receptor–positive/HER2-negative breast cancer from the early-stage to metastatic disease. Consideration of these complex clinical scenarios taken from tumor board discussions at the 42nd Annual Miami Breast Cancer Conference® highligh…

1
S13 Ep16: Liquid Imatinib Formulation Expands Leukemia Treatment Options and Improves Treatment Adherence: With Kate Gasparini, PharmD, BCOP, BCPPS 11:10

1M ago11:10

11:10

In today’s episode, supported by Shorla Oncology, we had the pleasure of speaking with Kate Gasparini, PharmD, BCOP, BCPPS, about the use of the oral formulation of imatinib (Imkeldi) for pediatric and adult patients with select leukemias and other malignancies. Gasparini is a pediatric oncology clinical pharmacy specialist at Memorial Sloan Ketter…

1
Trans Anger and Feminist Solidarity with Taina Brown 58:04

1M ago58:04

58:04

In this episode, Becky Mollenkamp and Taina Brown dive deep into Sylvia Rivera’s 2001 speech, "Bitch on Wheels." They unpack Rivera’s righteous rage, explore the erasure of trans voices in LGBTQ history, and reflect on the importance of solidarity and intersectionality in the fight for liberation. This raw speech from a legendary activist is just a…

1
S13 Ep15: The Expanding Role of AR Inhibition in mHSPC Management: With Alicia Morgans, MD, MPH 11:25

1M ago11:25

11:25

In our exclusive interview, Dr Morgans detailed the evolving role of AR inhibitors in the mHSPC setting, including the recent expanded approval for darolutamide (Nubeqa) for this population. She discussed treatment considerations for determining whether to give docetaxel along with darolutamide; other factors to remember with AR inhibition; and the…

1
DYKWYB: Ecclesiology 2 23:34

1M ago23:34

23:34

We’re supposed to be unified…right?

1
S13 Ep14: Revumenib Shows Promise Across Menin-Sensitive AML Subtypes and Could Shift Treatment Paradigms: With Naval Daver, MD 11:04

1M ago11:04

11:04

In today’s episode, we spoke with Naval Daver, MD, about the evolving role of menin inhibition in acute myeloid leukemia (AML) and emerging data with revumenib (Revuforj) presented across ongoing clinical trials. Dr Daver is a professor in the Department of Leukemia and director of the Leukemia Research Alliance Program at The University of Texas M…

1
S13 Ep13: T-DXd Plus Pertuzumab Could Redefine First-Line HER2+ Breast Cancer Management: With Paolo Tarantino, MD 14:41

1M ago14:41

14:41

In today’s episode, we spoke with Paolo Tarantino, MD, about key updates in HER2-positive breast cancer presented at the 2025 ASCO Annual MeetingBy OncLive® On Air

1
S13 Ep12: Telisotuzumab Vedotin Shakes Up Management of Pretreated, c-MET–Overexpressing NSCLC: With Jonathan W. Goldman, MD 9:26

1M ago9:26

9:26

In today's episode, we spoke with Jonathan W. Goldman, MD, about the phase 2 LUMINOSITY study (NCT03539536) evaluating telisotuzumab vedotin-tllv (Teliso-V; Emrelis) in patients with c-MET protein–overexpressing, nonsquamous, EGFR wild-type advanced non–small cell lung cancer (NSCLC). Dr Goldman is a professor of medicine in the Division of Hematol…

1
We Should All Be Feminists: A Deep Dive with Faith Clarke 57:04

1M ago57:04

57:04

In this powerful conversation, Becky Mollenkamp and Faith Clarke unpack Chimamanda Ngozi Adichie’s iconic essay *We Should All Be Feminists*. They explore how feminism intersects with race, colonization, shame, and identity. Faith shares deep insights from a Black Caribbean lens, and the two reflect on how culture is created—and can be disrupted. T…

1
S13 Ep11: Collaborative Structural Reforms Represent a Way Forward for Oncology Innovations: With Elizabeth Mittendorf, MD, PhD, MHCM 9:48

1M ago9:48

9:48

In today’s episode, we sat down for part 2 of our discussion with Elizabeth Mittendorf, MD, PhD, MHCM, the 2026-2027 president-elect of the American Society of Clinical Oncology (ASCO). Dr Mittendorf holds numerous leadership roles, including the Robert and Karen Hale Distinguished Chair in Surgical Oncology and vice chair for research in the Depar…

1
S13 Ep10: Updates and Innovations in Non-Opioid Pain Management Strategies for Breast Cancer Patients Post-Surgical Intervention 1:32:30

2M ago1:32:30

1:32:30

This PER® featured podcast includes a discussion with 3 experts on best practices for integrating opioid-sparing strategies into the treatment paradigm along with updates including the 2025 NOPAIN Act. The panel includes members of the care team including the surgical oncologist and anesthesiologist. This program is designed to help clinicians reco…

1
Love as Liberation: Unpacking bell hooks (with Heather Vickery) 55:07

2M ago55:07

55:07

✍️ This week’s essay: “Love as the Practice of Freedom” by bell hooks 🎙 This week’s guest: Heather Vickery is a coach, speaker, podcast host, and joy-bringer. Her work centers around intentional living, courageous leadership, and aligning action with values. Heather brings radical honesty and warmth to everything she does—even when it’s tough love.…

1
S13 Ep9: Multidisciplinary Collaboration and Mentorship Lay the Foundation for a New Chapter of ASCO Leadership: With Elizabeth Mittendorf, MD, PhD, MHCM 12:53

2M ago12:53

12:53

In today’s episode, we had the pleasure of speaking with Elizabeth Mittendorf, MD, PhD, MHCM, the 2026 president-elect of ASCO. Dr Mittendorf is the Robert and Karen Hale Distinguished Chair in Surgical Oncology and the vice chair for research in the Department of Surgery at the Brigham and Women's Hospital; co-leader of the Breast Program and dire…

1
S13 Ep8: Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma 54:11

2M ago54:11

54:11

This Oncology PER®Spectives™ podcast examines the recent advancements in the treatment landscape for advanced melanoma. In this activity, experts Yana Najjar, MD; Rahul A. Sheth, MD, FSIR; and Douglas Johnson, MD, MSCI, discuss the challenges of immune checkpoint inhibitor resistance and the practical strategies for overcoming this by using direct …

1
DYKWYB: Ecclesiology 1 27:06

2M ago27:06

27:06

Foundational church elements from Acts 2

1
S13 Ep7: Evolving Molecular Profiling and Liquid Biopsy Practices Guide First-Line CRC Therapy Decisions: With Chandler Park, MD; and Midhun Malla, MD 9:09

2M ago9:09

9:09

Drs Park and Malla began by talking through the clinical utility of ctDNA in patients with stage II and III colon cancer. Dr Malla referenced the DYNAMIC (ACTRN12615000381583) and observational BESPOKE CRC (NCT04264702) trials, noting that ctDNA serves as a prognostic biomarker for recurrence and is increasingly used to guide post-surgical surveill…

1
S13 Ep6: FDA Approval Insights: Perioperative Durvalumab Plus Chemo in MIBC: With Matthew Galsky, MD 7:48

2M ago7:48

7:48

In today’s episode, we spoke with Matthew Galsky, MD, about the FDA approval of neoadjuvant durvalumab (Imfinzi) plus gemcitabine and cisplatin followed by adjuvant durvalumab monotherapy after radical cystectomy for the treatment of adult patients with muscle-invasive bladder cancer (MIBC). Dr Galsky is a professor of medicine (hematology and medi…

1
Intersectional Feminism vs. Girlboss Feminism: Chatting about Lindy West with Paige Worthy 58:49

2M ago58:49

58:49

This week’s text: ✍️ “What No One Else Will Tell You About Feminism” by Lindy West This week’s guest: Paige Worthy (she/her) is a writer, editor, and brand messaging strategist for progressive entrepreneurs. Known for her spicy takes, thoughtful wordcraft, and zero tolerance for misogynist bullshit, Paige shows up in business and life as a truth-te…

1
S13 Ep5: Social Media Expands Access to Practical Public Health Education: With Chandler Park, MD; and Paul Hanona, MD 8:56

2M ago8:56

8:56

In this week’s episode of MedNews Week’s Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Paul Hanona, MD, to give advice to up-and-coming oncology content creators. Dr Hanona is a content creator under the handle @doctordiscover. In the final part of this 3-part se…

1
DYKWYB: The Christian Life 5 36:04

2M ago36:04

36:04

Developing a Good Devotional Life

1
DYKWYB: The Christian Life 4 31:20

2M ago31:20

31:20

Living empowered lives through Christ

1
S13 Ep4: Eltrombopag Biosimilar Improves Accessibility for Immune Thrombocytopenia & Aplastic Anemia: With Kanwarpal S. Kahlon, MD 8:24

2M ago8:24

8:24

In today’s episode, supported by Camber Pharmaceuticals, we spoke with Kanwarpal S. Kahlon, MD, an associate clinical professor of medicine at the UCLA School of Medicine. In our exclusive interview, Dr Kahlon discussed the significance of the commercial availability of the generic, AB-rated formulations of eltrombopag (Promacta), a bioequivalent m…

1
Objectification Begins With Words: Reading Robin Wall Kimmerer with Nancy Harris 47:54

2M ago47:54

47:54

This week’s text: ✍️ “Speaking of Nature” by Robin Wall Kimmerer This week’s guest: Nancy Harris (she/her) is an executive coach, keynote speaker, and facilitator supporting leaders and organizations committed to equity, people-centered work, and transformational change. She’s the founder of Restart Consulting, host of The Intersection podcast, and…

Podcasts Worth a Listen

Xavier Small Podcasts

Podcasts Worth a Listen

Quick Reference Guide